Page - (000254) - in Biomedical Chemistry: Current Trends and Developments
Image of the Page - (000254) -
Text of the Page - (000254) -
8 Significance of the N- and C-terminus
9 N-terminal esterification (phosphoester) or pegylation modifications to enhance plasma
stability (e.g. resistance to exopeptidases) and to reduce immunogenicity. Pegylation is
also designed to make the peptide larger (generally > 50 kDa) to retard excretion through
the kidneys (renal clearance)
Alternative routes for the administration of peptide-based drugs have
been improved in recent years and novel peptide delivery technologies
have emerged, including controlled-release parental drug, mucosal
route, oral route and transdermal route (Pettit & Gombotz, 1998). In spite
of some limitations, synthetic therapeutic peptides present numerous
advantages compared with their homologous compounds (proteins and
antibodies) and with small organic molecules, thanks to progress in
chemical synthesis and routes of administration (Vlieghe, 2010). In
Table 3.1.5, the principal advantages of peptides over
proteins/antibodies or over small organic molecules that make up
traditional medicines are presented.
Table 3.1.5: Advantages of peptides over other drug candidates as proteins/antibodies or
organic molecules (Loffet, 2002; Lien & Lowman, 2003; Witt & Davis, 2006; Vlieghe, 2010;
McGregor, 2008; Hummel, 2006).
Proteins and antibodies Organic molecules
Peptides have the potential to
penetrate further into tissues
owing to their smaller size and
charge
Therapeutic peptides are generally
less immunogenic than
recombinant proteins and
antibodies
Lower manufacturing costs
(synthetic vs. recombinant
production)
Higher activity per unit mass Organic molecules often represent
the smallest functional part of a
protein, offering greater efficacy,
selectivity and specificity
The degradation products of
peptides are amino acids
(minimizing the risks of systemic
toxicity or drug-drug interactions
Because of their short half-life, few
peptides accumulate in tissues
(reduction of risks of complications
caused by their metabolites)
Biomedical Chemistry: Current Trends and Developments
- Title
- Biomedical Chemistry: Current Trends and Developments
- Author
- Nuno Vale
- Publisher
- De Gruyter Open Ltd
- Date
- 2016
- Language
- English
- License
- CC BY-NC-ND 4.0
- ISBN
- 978-3-11-046887-8
- Size
- 21.0 x 29.7 cm
- Pages
- 427
- Keywords
- Physical Sciences, Engineering and Technology, Chemistry, Organic Chemistry, Green Chemistry
- Categories
- Naturwissenschaften Chemie